A study on role of topical application of mitomycin c postoperatively in reducing adhesions/synechiae after FESS in patients with chronic rhinosinusitis: A Randomized controlled trial.

Data suggested that low-dose mitomycin-c significantly reduces adhesions and improves nasal symptoms in the early postoperative period for chronic rhinosinusitis patients. These results align with previous research, supporting mitomycin-c as a valuable adjunctive therapy in sinus surgery. Future studies are recommended to explore varying dosages and application methods for potential differences in outcomes.